{"id":"https://openalex.org/W2020786996","doi":"https://doi.org/10.1158/1538-7445.am2012-4637","title":"Abstract 4637: Cell penetrating antibodies for intracellular targets: Expanding the antibody-based treatments for cancer","display_name":"Abstract 4637: Cell penetrating antibodies for intracellular targets: Expanding the antibody-based treatments for cancer","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2020786996","doi":"https://doi.org/10.1158/1538-7445.am2012-4637","mag":"2020786996"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-4637","doi":"https://doi.org/10.1158/1538-7445.am2012-4637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026107561","display_name":"Richard S. Agnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S. Agnes","raw_affiliation_strings":["1Case Western Reserve Univ., Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve Univ., Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013023933","display_name":"Masahiro Hitomi","orcid":"https://orcid.org/0000-0002-0937-6640","observed_orcids":["https://orcid.org/0000-0002-0937-6640"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masahiro Hitomi","raw_affiliation_strings":["2Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067133924","display_name":"James P. Basilion","orcid":"https://orcid.org/0000-0002-8659-3307","observed_orcids":["https://orcid.org/0000-0002-8659-3307"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P. Basilion","raw_affiliation_strings":["1Case Western Reserve Univ., Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Case Western Reserve Univ., Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"4637","last_page":"4637"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5889000296592712,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.35839998722076416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.021800000220537186,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cell-penetrating-peptides","display_name":"cell-penetrating peptides","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antibody-conjugates","display_name":"antibody conjugates","score":0.49799999594688416},{"id":"https://openalex.org/keywords/intracellular-targets","display_name":"intracellular targets","score":0.6959999799728394},{"id":"https://openalex.org/keywords/eg5","display_name":"Eg5","score":0.6779999732971191},{"id":"https://openalex.org/keywords/monastrol","display_name":"monastrol","score":0.6179999709129333},{"id":"https://openalex.org/keywords/mitotic-inhibition","display_name":"mitosis inhibition","score":0.6660000085830688},{"id":"https://openalex.org/keywords/rpa1","display_name":"RPA1","score":0.8169999718666077},{"id":"https://openalex.org/keywords/antimitotic-agents","display_name":"antimitotic agents","score":0.6579999923706055},{"id":"https://openalex.org/keywords/antibody-based-cancer-therapy","display_name":"antibody-based cancer therapy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cellular-internalization","display_name":"cellular internalization","score":0.6330000162124634},{"id":"https://openalex.org/keywords/bioconjugates","display_name":"bioconjugates","score":0.7110000252723694},{"id":"https://openalex.org/keywords/cell-cycle-synchronization","display_name":"cell cycle synchronization","score":0.7149999737739563},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.6359999775886536},{"id":"https://openalex.org/keywords/neutralizing-activity","display_name":"neutralizing activity","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.667130708694458},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6641943454742432},{"id":"https://openalex.org/C93304396","wikidata":"https://www.wikidata.org/wiki/Q14763008","display_name":"Mitosis","level":2,"score":0.6072774529457092},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.5265146493911743},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5067031979560852},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5040794610977173},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4774249792098999},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45180195569992065},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4113348424434662},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3681713938713074},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.351410835981369},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2686077952384949},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25135669112205505},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20104911923408508},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-4637","doi":"https://doi.org/10.1158/1538-7445.am2012-4637","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-4637","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7699999809265137,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1983608325","https://openalex.org/W2994631997","https://openalex.org/W1509080402","https://openalex.org/W3014699470","https://openalex.org/W2060976998","https://openalex.org/W3196042122","https://openalex.org/W3213557594","https://openalex.org/W2166523454","https://openalex.org/W3011841843","https://openalex.org/W4392714833"],"abstract_inverted_index":{"Abstract":[0],"Antibody":[1],"based":[2],"therapeutics":[3,342],"have":[4,17,33,48,121,168,239],"gained":[5,169],"significant":[6],"interest":[7],"in":[8,73,129,164,182],"recent":[9],"years.":[10],"Herceptin,":[11],"which":[12],"targets":[13,316],"cell":[14,38,50,59,116],"surface":[15,39],"protein,":[16],"been":[18,34],"successful":[19],"for":[20,30,260,343,364],"the":[21,55,88,93,99,127,165,188,252,261,273,281,293,321,337,356,361],"treatment":[22],"of":[23,57,82,92,143,190,198,255,339,355,360],"cancer.":[24],"While":[25,102],"antibodies":[26,32,52,340],"are":[27,141,155,233,317],"promising":[28],"platforms":[29],"therapy,":[31],"limited":[35],"to":[36,122,194,216,228,235,305,319,335],"targeting":[37],"proteins":[40,162],"because":[41],"they":[42],"cannot":[43],"penetrate":[44,236,248],"cells.":[45],"Recently,":[46,160],"we":[47,147,220],"developed":[49],"penetrating":[51,60],"engineered":[53],"from":[54,98],"conjugation":[56],"a":[58,105,149,284],"peptide":[61],"(CPP)":[62],"and":[63,68,87,115,184,211,238,250,297,323,332],"an":[64,133,179,195,225,300],"antibody.":[65],"The":[66],"CPP-mIgG":[67],"CPP-anti-RPA1":[69,94],"IgGs":[70],"were":[71,85,95,290],"internalized":[72],"cells":[74,237,249,289,322],"as":[75,132,209,224,277,341],"observed":[76],"by":[77,258],"fluorescence":[78],"microscopy.":[79],"Biological":[80],"activities":[81],"these":[83,309],"conjugates":[84,246],"determined":[86],"expected":[89],"anti-proliferative":[90],"effects":[91],"subtly":[96],"distinguishable":[97],"control":[100,295],"CPP-mIgG.":[101],"RPA1":[103],"is":[104],"valid":[106],"anti-cancer":[107],"target,":[108],"its":[109],"function":[110],"depends":[111],"on":[112],"complicated":[113],"pathways":[114],"cycle":[117,287],"where":[118],"dosing":[119],"may":[120],"be":[123],"optimized.":[124],"This":[125],"demonstrates":[126],"difficulties":[128],"establishing":[130],"CPP-IgG":[131,139,231,313],"efficient":[134],"therapeutic.":[135],"To":[136],"demonstrate":[137,229],"that":[138,230,244,312],"bioconjugates":[140,232],"capable":[142],"inducing":[144],"biological":[145,275],"effects,":[146],"sought":[148],"different":[150],"intracellular":[151,226,315,344],"target.":[152],"Antimitotic":[153],"drugs":[154],"standard":[156],"cancer":[157,345],"chemotherapeutic":[158],"agents.":[159],"other":[161],"involved":[163],"mitotic":[166],"machinery":[167],"much":[170],"attention.":[171],"For":[172],"example,":[173],"kinesin":[174],"motor":[175],"protein":[176,223,257],"Eg5":[177,186,222,256],"plays":[178],"important":[180],"role":[181],"mitosis":[183],"inhibiting":[185],"prevents":[187],"formation":[189],"bipolar":[191],"spindles":[192],"resulting":[193],"unmistakable":[196],"change":[197],"morphology":[199,263],"during":[200,264],"mitosis_a":[201],"star-like":[202,302],"structure":[203,303],"called":[204],"\u201cmonoastral\u201d.":[205],"Small":[206],"molecules,":[207],"such":[208],"monastrol":[210],"(S)-trityl":[212],"cysteine":[213],"(STLC),":[214],"lead":[215],"monastral":[217],"formation.":[218],"Thus,":[219],"chose":[221],"target":[227],"able":[234,318],"neutralizing":[240],"activity.":[241],"We":[242,266,279,327],"expect":[243],"CPP-anti-Eg5":[245,269,298],"will":[247,271,328],"produce":[251],"canonical":[253],"inhibition":[254],"observing":[259],"monoastral":[262],"mitosis.":[265],"tested":[267],"whether":[268],"IgG":[270],"present":[272],"same":[274],"activity":[276],"STLC.":[278],"bioconjugated":[280],"anti-Eg5":[282],"with":[283,292],"CPP.":[285],"Cell":[286],"synchronized":[288],"treated":[291],"positive":[294],"STLC":[296],"showed":[299],"atypical":[301],"similar":[304],"monoastral.":[306],"In":[307],"whole,":[308],"studies":[310],"show":[311,324],"against":[314],"enter":[320],"inhibitory":[325],"activities.":[326],"describe":[329],"our":[330],"progress":[331],"discuss":[333],"approaches":[334],"expanding":[336],"utility":[338],"targets.":[346],"Citation":[347],"Format:":[348],"{Authors}.":[349],"{Abstract":[350],"title}":[351],"[abstract].":[352],"In:":[353],"Proceedings":[354],"103rd":[357],"Annual":[358],"Meeting":[359],"American":[362],"Association":[363],"Cancer":[365,376],"Research;":[366],"2012":[367],"Mar":[368],"31-Apr":[369],"4;":[370],"Chicago,":[371],"IL.":[372],"Philadelphia":[373],"(PA):":[374],"AACR;":[375],"Res":[377],"2012;72(8":[378],"Suppl):Abstract":[379],"nr":[380],"4637.":[381],"doi:1538-7445.AM2012-4637":[382]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}